As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At Talis Biomedical, a filing with the SEC revealed that on Wednesday, Director Matthew L. Posard bought 62,500 shares of TLIS, at a cost of $16.00 each, for a total investment of $1M. Posard was up about 53.0% on the buy at the high point of today's trading session, with TLIS trading as high as $24.48 in trading on Monday. Talis Biomedical is trading up about 5.7% on the day Monday. This buy marks the first one filed by Posard in the past year.
And also on Wednesday, EVP, CFO Matthew Alan Switzer bought $644,000 worth of Southern National Bancorp Of Virginia, buying 50,000 shares at a cost of $12.88 each. This purchase marks the first one filed by Switzer in the past twelve months. Southern National Bancorp Of Virginia is trading up about 1.7% on the day Monday. So far Switzer is in the green, up about 6.1% on their purchase based on today's trading high of $13.67.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.